End-to-end medtech services provider ClariMed, Inc. has announced the appointment of Xin Zhang as the company’s new Chief Financial Officer (CFO) and Head of Corporate Development.
Zhang is an experienced company director and private equity investor in mid-market companies with a focus on long-term sustainable growth, change management and value creation.
The new CFO brings extensive financial leadership experience to ClariMed, having previously worked as Vice President at Imperial Capital, where he served on the Board of Directors for three companies and led the launch of two healthcare services platform investments.
He has also worked in M&A investment banking at Citi and earned his CPA at PwC.
ClariMed CFO, Kelley Kendle, said:
“Xin is passionate about being part of an operating team.
“His experience, vision, and enthusiasm about joining our team and building something meaningful together make him the perfect fit for our organisation as we continue to grow, expand our investments and reaffirm our dedication to strategic acquisitions.”
In his new role, Zhang will be responsible for overseeing all financial operations, managing the company’s financial strategy,and driving corporate development initiatives.
Zhang will play a crucial role in supporting ClariMed’s growth strategy, enhancing financial performance and ensuring the company’s long-term sustainability..
Xin Zhang said: “ClariMed’s mission, current success, and future growth potential are compelling.
“I am thrilled to join ClariMed at this exciting time and eagerly anticipate working in collaboration with the ClariMed leadership team, the ClariMed companies, UserWise and Harvey Medical, and NaviMed, our private equity partner.”
